I am/have/had
I am looking for
Advanced Filters
Found 1 clinical trials
Camrelizumab in Combination With Apatinib in Refractory and Relapsed DLBCL
This study will evaluate the efficacy and safety of camrelizumab in combination with apatinib in in patients with relapsed or refractory diffuse large B cell lymphoma failed from second line chemotherapy.
measurable disease
prothrombin time (pt)
follicular lymphoma grade iiib
blood transfusion
thyroid dysfunction
- 0 views
- 19 Feb, 2024